Charles Schwab Investment Management Inc V Tv Therapeutics Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.27 - $3.44 $47,547 - $72,054	-20,946 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.74 - $3.19 $36,446 - $66,817	20,946 New	20,946 $48,000
Q2 2018 Aug 08, 2018	SELL	$0.71 - $4.04 $8,662 - $49,288	-12,200 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$3.9 - $7.77 $47,580 - $94,794	12,200	12,200 $74,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.